Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of the present trial is to investigate the effects of omega-3 PUFAs in individuals aged 12-26 years with 22q11DS at ultra-high risk for developing a first episode of psychosis.
Epistemonikos ID: d0ffa3093d7f9db7bdf0251f8d7e5f229635bbfc
First added on: May 11, 2024